K-R01 Transition to Independence Program
LOI and RFA
TIMELINE
Letters of intent to apply are required by 11:59 p.m. on February 1, 2024. *EXTENDED to 11:59 p.m. Thursday, February 8, 2024
Invitations for full applications will be sent by February 5, 2024 *EXTENDED to February 12, 2024
Full applications due 11:59 p.m. on March 18, 2024
Interviews for highly rated applicants will be held May 6-7, 2024
Award decisions will be announced May 2024
Up to 3 awards will be issued for this RFA to begin July 1, 2024
HIGHLIGHTS
$50,000 research funds to be expended over 2 years
Receive specialized career development geared towards developing your R01 proposal
Must be an assistant professor or associate professor (in rank 4 years or less) with a primary mentor and data scientist
Applicants must have held an active K or equivalent career development award for at least one year at the time of application OR have successfully concluded a K award on or after January 4, 2023
Applicants must have a minimum of 50% time protected from other expectations (clinical/education/service) and devoted to research for the entire period of the award. This time can derive from an ongoing K award, Departmental/Program support, other research grants with salaried effort, etc.
Up to 3 awards will be issued for this RFA
NATURE AND PURPOSE OF THIS RFA
The Clinical and Translational Science Institute (CTSI) K-R01 Transition to Independence Program is designed to support faculty by providing mentorship, oversight, programming, and pilot funds. Programming includes structured discussions to critique and provide feedback on the plan for submitting an R type grant, individualized critique sessions, and constructing a timeline for R submission. This two-year program aims to place early-stage investigators with active or very recent K awards on the path toward R01 awards. This RFA is planned to be issued annually. Success of this program will be judged by the number of awardees who secure NIH R01 grants and/or R01 equivalent funding for clinical and translational research. The K-R01 program is directed by Kim Mansky, PhD.
Underrepresented minorities (URM) in medicine applicants or those with disadvantaged backgrounds as defined by the NIH are strongly encouraged to apply and will receive some advising on crafting their applications; please be sure to indicate URM status in the LOI submission. Questions can be directed to Shelly Hubbling at ctsieduc@umn.edu.